---
document_datetime: 2023-09-21 17:00:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/faslodex-epar-all-authorised-presentations_en.pdf
document_name: faslodex-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0395408
conversion_datetime: 2025-12-15 20:00:38.670603
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength    | Pharmaceutical         | Route of          | Packaging                  | Content   | Package size                             |
|-----------------|-----------------|-------------|------------------------|-------------------|----------------------------|-----------|------------------------------------------|
| EU/1/03/269/001 | Faslodex        | 250 mg/5 ml | Solution for injection | Intramuscular use | pre-filled syringe (glass) | 5 ml      | 1 pre-filled syringe + 1 safety needle   |
| EU/1/03/269/002 | Faslodex        | 250 mg/5 ml | Solution for injection | Intramuscular use | pre-filled syringe (glass) | 5 ml      | 2 pre-filled syringes + 2 safety needles |